Le Lézard
Classified in: Health
Subject: TRI

ASU adds diversity to $8.6 million Mayo Clinic-led network for patient-centered research


TEMPE, Ariz., Nov. 30, 2017 /PRNewswire/ -- Arizona State University (ASU) has joined a national initiative that brings patients, researchers, health systems and clinicians together to help people make informed healthcare decisions and improve healthcare delivery and outcomes. That innovative initiative is the National Patient-Centered Clinical Research Network (PCORnet) funded by the Patient-Centered Outcomes Research Institute (PCORI). PCORnet is a national evidence generation system of large, highly representative health and healthcare data that supports clinical research.

Healthcare research needed a different approach. It has been too slow, too expensive, not always answering the important questions. Healthcare decision-making is always informed by evidence. Health outcomes and disparities were not improving. Change was needed, but how?

PCORI answered with a national system addressing the problems of traditional clinical research that continuously learns and grows in quality and efficiency. ASU's Center for Health Information & Research (CHiR), directed by George Runger, PhD, contributes claims and clinical data from its repository of health information as a member of the Patient-Centered Network of Learning Health Systems (LHSNet), a PCORnet Clinical Data Research Network (CDRN).

LHSNet is comprised of 12 million patients across seven member institutions, led by the Mayo Clinic. The network provides expertise to support research that improves health and health care in ways meaningful to its ethnically and socioeconomically diverse patient population, their families, and providers.

LHSNet is operating under a three-year award of more than $8.6 million from PCORI.

According to Runger, "Our patient population is one of CHiR's key assets that benefits LHSNet and PCORnet." With Arizona being home to large numbers of Hispanics/Latinos and Native Americans, CHiR brings a unique diversity of patients to all types of research studies. Electronic medical records from local community health centers and Maricopa County's public teaching hospital enrich the data from Arizona Medicaid.

CHiR also has a long history of joining forces with local health provider organizations to improve health and health care in Arizona. "We are excited about taking our data sharing relationships to the national level and engaging local providers in new research opportunities that will benefit their patients."

LHSNet conducts research internally among its member institutions and at the PCORnet level. PCORnet creates the infrastructure, tools and policies to support rapid and efficient research. PCORnet embodies a "network of networks" made up of:

Together, they represent more than 128 million patients with medical encounters over the last five years. Additional cross-network Collaborative Research Groups composed of content experts and niche Research Interest Groups intensify the research power of PCORnet.

PCORnet data comes from multiple sources, including:

The data is organized under a Common Data Model to precipitate faster data analysis and allow each network to use different platforms and yet share information under common definitions. Capacity is building every day as PCORnet seeks new ways to enhance the data and expertise it offers.

The door is open and ASU welcomes potential investigators, patient groups, healthcare organizations, clinicians and clinician groups, government, industry scientists, and sponsors to leverage LHSNet's and PCORnet's unique infrastructure and collaborate on patient-centered clinical research from study development to planning to implementation.

Benefits

About CHiR

CHiR is a multidisciplinary unit that serves as a resource, tool, and collaborator for individuals and organizations that need health information for public, private and research uses. Our repositories provide one of the most complete and accurate profiles of individual and population information on health conditions, health care utilization, health care costs, and health insurance, vastly reducing the time, technology, and cost for individual organizations to collect such data themselves. More information is available at chs.asu.edu/chir.

About LHSNet

The Patient-Centered Network of Learning Health Systems (LHSNet) is a PCORI funded Clinical Data Research Network (CDRN) designed to support research that improves health care in ways meaningful to patients, their families, and providers. LHSNet brings together 7 diverse institutions all with clinical data that is curated to support cutting edge research. Our collaboration has exceptional expertise in cutting-edge informatics, patient and clinician engagement, and pragmatic clinical trials development. LHSNet is involved in multiple research studies. More information is available at www.lhsnet.org.

About PCORI

PCORI is an independent, nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better-informed healthcare decisions. To date, PCORI has awarded more than $2 billion to more than 600 research-related projects in patient-centered outcomes research. More information is available at www.pcori.org and www.pcornet.org.

Media Contact:
Jodi Amendola for ASU
Amendola Communications
602-614-3182
[email protected]

 

SOURCE Arizona State University (ASU)


These press releases may also interest you

at 10:31
Recently, GenScript Biotech Corporation (HK.1548), a world leader in technologies and services for life science R&D and manufacture, released its 2023 Environmental, Social, and Governance (ESG) report. This report showcases the company's dedicated...

at 10:30
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0% from 2024 to 2029 according to a new report by MarketsandMarketstm. Similarly, the vaccines...

at 10:25
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that updated Phase 1/2 data for AU-007 will be presented at the American Society...

at 10:20
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and Resilience...

at 10:20
Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced clinical data from the pivotal Phase 2 study of PRGN-2012 AdenoVerse immunotherapy...

at 10:20
The two poster presentations will report -first combination data from the Phase 1/2a study with BI-1808 in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), as well as an update on monotherapy armcombination data from the...



News published on and distributed by: